✔ Introduction: Timing Matters in Hypertension Control If you take medication for high blood pressure, you’ve probably wondered: “Should I take my medication in the morning? Or would it work better at night?” This is… Should You Take Blood Pressure Medication in the Morning or at Night?
“After taking cholesterol pills, my liver got worse.”“My muscles ache—could this be due to statins?”“I’ve heard statins can cause diabetes. Should I still take them?”“My mother is over 80. Does she really need a statin?”… Statins: Misunderstood Truths About Liver, Muscles, Diabetes, and Elderly Use
Is HDL Cholesterol Always Beneficial? High-density lipoprotein cholesterol (HDL-C) is generally known as “good cholesterol” due to its role in reverse cholesterol transport and cardiovascular protection. However, a 2024 study published in Scientific Reports by… Can High HDL Cholesterol Increase the Risk of Diabetic Kidney Disease?
❗ Why Early Treatment Matters Chronic kidney disease (CKD) affects approximately 10% of the global population. The more concerning fact is that the leading cause of death in CKD patients is not kidney failure but… Chronic Kidney Disease: Treatment Should Start Sooner
The optimal blood pressure target for kidney transplant recipients remains a subject of debate. While multiple studies have confirmed that hypertension negatively impacts graft survival, there is still a lack of clear clinical evidence regarding… Optimal Blood Pressure Targets for Kidney Transplant Recipients: Evolution of Research and Best Practices
Recently, SGLT2 inhibitors (SGLT2i) have been proven to provide cardiovascular and renal protection for patients with chronic kidney disease (CKD), effectively slowing renal function decline and reducing proteinuria and blood pressure, regardless of diabetes status.… Effects and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: Insights from the GREAT-ASTRE Study
Chronic kidney disease (CKD) and end-stage renal disease (ESRD) gradually impair kidney function, disrupting the balance of essential micronutrients. Some nutrients are prone to deficiency, while others accumulate due to impaired excretion, leading to toxicity.… Micronutrient Management in Kidney Disease Patients: Risks of Deficiency and Overconsumption
Please check the names of the medications you are taking to see if they include a PPI or H2RA. If you are taking both together, make sure to review this with your doctor. Recent Study… The Increased Risk of Osteoporotic Fractures with PPI and H2RA Combination Therapy
sGC Activators for Mitigating Ischemic Kidney Injury: Research Summary Recent studies have demonstrated that Soluble Guanylyl Cyclase (sGC) activators can effectively mitigate ischemia-reperfusion injury (IRI) in the kidneys. Researchers have explored the potential of the… sGC Activators for Mitigating Ischemic Kidney Injury: A Breakthrough in Renal Protection
Summary This post explores Ezetimibe as a non-statin therapy for treating dyslipidemia, based on the latest research and clinical insights. Statins are the most commonly prescribed medications for managing low-density lipoprotein cholesterol (LDL-C), but not… Managing Dyslipidemia with Ezetimibe as a Non-Statin Therapy